23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 151.27 | -2.13 | -1.39% | 4:00 pm GMT-4 | 7.47M | 7.43M | 364.06B |
ABBV | AbbVie Inc. | 164.56 | -1.86 | -1.12% | 4:00 pm GMT-4 | 3.01M | 5.60M | 290.59B |
PFE | Pfizer Inc. | 28.53 | -0.11 | -0.38% | 4:00 pm GMT-4 | 21.56M | 42.53M | 161.67B |
SNY | Sanofi | 48.42 | -0.25 | -0.51% | 4:00 pm GMT-4 | 1.24M | 1.98M | 121.10B |
REGN | Regeneron Pharmaceuticals, Inc. | 987.27 | +4.98 | +0.51% | 4:00 pm GMT-4 | 310.81k | 456.29k | 108.78B |
GSK | GSK plc | 44.59 | -0.39 | -0.87% | 4:00 pm GMT-4 | 5.15M | 3.16M | 93.22B |
GILD | Gilead Sciences, Inc. | 67.9 | +0.18 | +0.27% | 4:00 pm GMT-4 | 3.68M | 6.93M | 84.59B |
MRNA | Moderna, Inc. | 141.01 | +8.11 | +6.10% | 4:00 pm GMT-4 | 4.47M | 3.84M | 54.04B |
TAK | Takeda Pharmaceutical Company Limited | 13.28 | +0.06 | +0.45% | 4:00 pm GMT-4 | 594.35k | 1.63M | 41.95B |
BNTX | BioNTech SE | 92.47 | +1.86 | +2.05% | 4:00 pm GMT-4 | 340.91k | 593.72k | 22.28B |
NVAX | Novavax, Inc. | 14.79 | +1.78 | +13.68% | 4:00 pm GMT-4 | 14.03M | 13.08M | 2.18B |
VIR | Vir Biotechnology, Inc. | 9.69 | -0.04 | -0.41% | 4:00 pm GMT-4 | 551.31k | 971.32k | 1.32B |
INO | Inovio Pharmaceuticals, Inc. | 11.11 | -0.89 | -7.42% | 4:00 pm GMT-4 | 338.94k | 442.74k | 287.87M |
GSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 billion met their goals.
Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Paris, New York, N.Y., and San Francisco, CA, May 21, 2024. Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle. This represents a first collaboration of its kind w
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,529,599,938 €Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Regi